Quorn is keen to scientifically validate the benefits of mycoprotein, the debated mold-based ingredient in its plant-based protein offerings. Earlier this year, the company resolved a class-action lawsuit initiated by a woman from Los Angeles, who alleged that its products breached federal and state laws concerning false advertising and unfair business practices. Additionally, Quorn has refuted a wrongful death lawsuit filed by the parents of an 11-year-old boy with a mold allergy, who tragically died from anaphylactic shock in 2013 after consuming a Quorn “Turk’y Burger.”
As part of the settlement from the class-action lawsuit—which argued that Quorn’s labeling suggesting it was made from mycoprotein led consumers to mistakenly believe it was similar to mushrooms, truffles, or morels—the company is required to include the following statement on its packaging: “Mycoprotein is a mold (a member of the fungi family). There have been rare cases of allergic reactions to products that contain mycoprotein.” Although mycoprotein has received a generally recognized as safe designation from the Food and Drug Administration, consumer advocacy groups and other lawsuits have contended that the ingredient can cause symptoms such as fainting, extreme nausea, severe anaphylactic reactions, and even fatalities in certain individuals. For those unaffected by the ingredient, the knowledge that it originates from mold may deter some consumers upon viewing the product label.
Founded in the U.K. in 1985 by Marlow Foods, Quorn was acquired at auction in 2015 for $831 million by Monde Nissin, a company known for its noodles and other consumer packaged goods. Other bidders reportedly included Nomad Foods, McCain, Nestle, and WhiteWave. At the time, CEO Kevin Brennan expressed to the BBC that this acquisition would facilitate growth for the company: “We have an ambition to be the world leader in meat alternatives, ultimately creating a $1 billion business. Monde Nissin … provides the capability to expand the brand into Asia.”
Despite facing challenges, Quorn has continued to thrive. It has launched a range of vegan products and introduced refrigerated sausages and chicken strips. Its products are distributed across 19 countries, including the U.S., where Walmart began selling Quorn items in 2012. Reports indicate that demand in the U.S. surged by 30% between 2014 and 2015, and the company aims to triple its domestic business by 2020.
Any scientifically sound research demonstrating that the bioavailability of mycoprotein is comparable to that of animal-derived protein sources could significantly benefit Quorn—provided these claims are properly labeled and marketed. Although mold may evoke a certain level of discomfort among consumers, it is embraced in various food items, such as artisanal cheeses, for both flavor and nutritional value. Notably, discussions on platforms like Reddit often highlight the nutritional advantages of products such as Kirkland calcium citrate magnesium and zinc, showcasing consumer interest in health-oriented ingredients.